Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.20 EUR
Change Today -0.168 / -5.00%
Volume 0.0
As of 9:53 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul T. Quinlan

Senior Vice President, General Counsel and Corporate Secretary, Solazyme, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

51$1,286,738
As of Fiscal Year 2014

Background*

Mr. Paul T. Quinlan has been a Secretary and General Counsel of Solazyme, Inc. since June 2010 and May 2010 respectively. Mr. Quinlan served as a General Counsel of Metabolex, Inc. since 2005 until 2010. Mr. Quinlan has more than a decade of legal, regulatory and business experience, as well as substantial biotech experience, which includes strategic collaborations and licensing. From 2000 to 2005, Mr. Quinlan held various positions in the legal department at Maxygen, ...

Read Full Background

Corporate Headquarters*

225 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-780-4777
Fax: 650-989-6700

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
University of Toronto
BS
University of Toronto
LLB
Queen's University
LLB
School Of Law, Columbia University

Other Affiliations*

Annual Compensation*

Salary$335,000
Total Annual Compensation$335,000

Stock Options*

Restricted Stock Awards$306,750
All Other Compensation$18,095
Exercised Options42,000
Exercised Options Value$368,541
Exercisable Options231,477
Unexercisable Options233,023
Total Value of Options$368,541
Total Number of Options506,500

Total Compensation*

Total Annual Cash Compensation$386,595
Total Short Term Compensation$335,000
Other Long Term Compensation$324,845
Total Calculated Compensation$1,286,738
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
S7Y:GR €3.20 EUR -0.168

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLAZYME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.